Our data also show that this is neither dependent on the tumor model (B16F10) nor on the genetic background (C57BL6) or the experimental overexpression of VEGF-C, as PDL1 was also upregulated in a completely unrelated tumor model, the 4T1 breast cancer model in the Balb/c background. The gene discussed is VEGFC; the disease is breast cancer.